Saul Centers (BFS) director updates phantom stock, options and share ownership
Rhea-AI Filing Summary
Saul Centers, Inc. director reported updated equity holdings, including both common stock and deferred compensation awards. The filing shows beneficial ownership of 16,915 shares of common stock held directly.
In the deferred compensation program, the director holds a series of director stock options covering multiple grants of 2,500 shares of common stock each, with exercise prices ranging from $33.79 to $59.41 and expiration dates between May 6, 2026 and May 12, 2033.
The report also discloses an acquisition on January 2, 2026 of 634.316 phantom stock shares at a reference price of $31.53 under the company’s Deferred Compensation Plan for Directors, bringing total phantom stock holdings to 7,379.856 shares, which include 135.486 shares previously awarded as dividend reinvestments.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock | 634.316 | $31.53 | $20K |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan. The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement. Includes 135.486 shares awarded October 31, 2025 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the Deferred Compensation Plan.
FAQ
What insider activity did Saul Centers, Inc. (BFS) disclose in this Form 4?
The filing reports a director’s updated equity holdings in Saul Centers, Inc., including directly owned common stock, multiple director stock options, and phantom stock units awarded under the company’s deferred compensation arrangements.
What phantom stock award was reported for the Saul Centers (BFS) director?
On January 2, 2026, the director acquired 634.316 phantom stock shares under the Deferred Compensation Plan for Directors at a reference price of $31.53, increasing total phantom stock holdings to 7,379.856 shares.
What director stock options are reported for the Saul Centers (BFS) director?
The filing lists several director stock options, each for 2,500 shares of common stock, with exercise prices including $57.74, $59.41, $49.46, $55.71, $50, $43.89, $47.9, and $33.79, and expiration dates from May 6, 2026 through May 12, 2033, all held directly.
What role does the reporting person have at Saul Centers, Inc. (BFS)?
The reporting person is identified as a Director of Saul Centers, Inc., filing individually rather than jointly with other reporting persons.
Does the Saul Centers (BFS) filing mention dividend reinvestments in phantom stock?
Yes. The filing notes that the phantom stock total includes 135.486 shares that were awarded on October 31, 2025 as dividend reinvestments on phantom stock held under the Deferred Compensation Plan.